Author:
Zielonka T. M.,Zycinska K.,Radzikowska E.,Filewska M.,Bialas B.,Obrowski M. H.,Skopinska-Rozewska E.,Demkow U.
Reference31 articles.
1. Antoniou, K. M., Tzouvelekis, A., Alexandrakis, M. G., Sfiridaki, K., Tsiligianni, I., Rachiotis, G., Tzanakis, N., Bouros, D., Milic-Emili, J., & Siafakas, N. M. (2006). Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest, 130(4), 982–988.
2. ARA. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. (1980). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism, 23(5), 581–590.
3. ATS/ERS. (2002). International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine, 165(3), 277–304.
4. Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249–257.
5. Ebina, M., Shimizukawa, M., Shibata, N., Kimura, Y., Suzuki, T., Endo, M., Sasano, H., Kondo, T., & Nukiwa, T. (2004). Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 169(11), 1203–1208.